About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 2397   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size


 
  Table of Contents 
ORIGINAL ARTICLE
Year : 2019  |  Volume : 26  |  Issue : 4  |  Page : 210-215  

Prevalence and severity of diabetic retinopathy among diabetic patients presenting to a tertiary eye hospital in Nepal


1 Tilganga Institute of Ophthalmology, Kathmandu, Nepal
2 John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA
3 Florida Retina Institute, Jacksonville, FL, USA

Date of Submission11-Mar-2018
Date of Acceptance07-Oct-2019
Date of Web Publication29-Jan-2020

Correspondence Address:
Dr. Benjamin J Thomas
Florida Retina Institute, 8786 Perimeter Park Blvd, Jacksonville, FL 32216
USA
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/meajo.MEAJO_65_18

Rights and Permissions
   Abstract 


PURPOSE: The purpose of the study is to evaluate the prevalence and severity of diabetic retinopathy (DR) among all diabetic patients presenting to a tertiary eye care center in Nepal over a 3-year period.
MATERIALS AND METHODS: This was a retrospective review of all clinical records from the initial presentations of diabetic patients at the Tilganga Institute of Ophthalmology (TIO) from 2012 to 2014.
RESULTS: In total, 8855 patients were identified who presented to TIO with a prior diagnosis of diabetic mellitus (DM) during the study period. DR was found in 1714 patients (19.4%) at the time of initial presentation, 1305 (14.7%) of which had nonproliferative DR (PDR), while 617 (6.9%) demonstrated diabetic macular edema (DME) and 409 (4.6%) demonstrated PDR. Of the 1714 patients with DR, 825 (48.1%) required treatment at initial presentation for DME and/or PDR. Male gender, hypertension, age at presentation, and interval from diagnosis of DM to initial eye consultation were significantly associated with the presence of DR (P < 0.05).
CONCLUSIONS: The prevalence of DR among patients with DM was 19.4%, which is lower than previously published estimates. However, among patients diagnosed with DR, over half presented with a vision-threatening complication warranting some measure of initial treatment.

Keywords: Diabetes mellitus, diabetic macular edema, diabetic retinopathy, epidemiology, hypertension, Nepal, ocular comorbidities, tertiary eye hospital


How to cite this article:
Paudyal G, Shrestha MK, Poudel M, Tabin GC, Ruit S, Thomas BJ. Prevalence and severity of diabetic retinopathy among diabetic patients presenting to a tertiary eye hospital in Nepal. Middle East Afr J Ophthalmol 2019;26:210-5

How to cite this URL:
Paudyal G, Shrestha MK, Poudel M, Tabin GC, Ruit S, Thomas BJ. Prevalence and severity of diabetic retinopathy among diabetic patients presenting to a tertiary eye hospital in Nepal. Middle East Afr J Ophthalmol [serial online] 2019 [cited 2020 Feb 26];26:210-5. Available from: http://www.meajo.org/text.asp?2019/26/4/210/277268




   Introduction Top


Diabetic retinopathy (DR) is the leading cause of visual impairment among working-age individuals in the Western world, according to numerous large population-based studies.[1],[2] Detailed understanding of the prevalence of diabetes mellitus (DM) in a general population, as well as the association of DR with other detectable conditions (e.g., hypertension) allows for improved awareness, improved patterns of screening and treatment, and subsequently lower incidence and severity of vision loss.

This question is of critical importance in South Asia and specifically in Nepal. According to the World Health Organization, India has the largest diabetic population in the world, projected to reach 79.4 million by 2030.[3] However, previous population-based screening studies from Nepal have shown a higher percentage prevalence of DR than India,[4] a fact of significant public health concern for the country.

Initial large cross-sectional surveys examining the prevalence of DR were conducted predominately in Western nations; however, studies examining other, genetically diverse populations have been conducted around the world, including a number of smaller studies in Nepal [Table 1].[5],[6],[7],[8],[9],[10],[11] These studies have largely been hospital-based, cross-sectional examinations of various subsegments of the diabetic patients presenting to an institution, carried out prospectively over time periods less than a year, with a prevalence of DR ranging widely from 20.31% to 78%.[5],[6],[7],[8],[9] An additional Nepalese study examining diabetic patients who recruited through community screening found a lower prevalence of DR of 19.3%,[12] and a subsequent community-based study of known diabetics reported a slightly lower DR prevalence of approximately 12%.[13]
Table 1: Results of prior diabetic retinopathy studies from South Asia

Click here to view


This broad variability may simply reflect the diversity of subpopulations examined, the diversity of the Nepalese population presenting to hospitals in Kathmandu, or may be a result of smaller patient numbers examined. Similar studies from other countries in South Asia also present widely divergent prevalence figures, albeit from widely divergent populations and with variable study criteria.[10],[11],[14],[15] Larger studies are needed to clarify these numbers.

Along with examinations of DR prevalence alone, significant attention should be given to the severity of DR at presentation and the need for treatment. Early studies from populations in Southeast Asia and Oceania have shown that up to 10% of diabetic patients have vision-threatening DR at initial presentation, with up to 5% requiring treatment at this initial visit.[16],[17] Prior studies from Nepal have shown a prevalence of non-proliferative DR (NPDR) ranging from 13.28% to 61.4% and of PDR ranging from 0.08% to 16.7%.[5],[6],[8],[9] Again, a broad range of prevalence has been seen that warrants further clarification.

Within this context, we conducted a cross-sectional survey of diabetic patients presenting for ocular examination at the Tilganga Institute of Ophthalmology (TIO) from the years 2012–2014, focusing on the prevalence of DR, DR severity, and associated factors.


   Materials and Methods Top


The study was a retrospective, cross-sectional review of all clinical records from all patients presenting to the TIO with a prior diagnosis of DM, from the years 2012 to 2014. Due to the unique position of TIO within the community as both a tertiary eye care center and a charitable organization offering care to all presenting patients, these patients represent a broad cohort referred from both outside eye clinics and primary care, as well as self-referred patients, from around the Kathmandu Valley. As the largest population center in Nepal, a country of widely divergent ethnicities, these patients also represent the most heterogeneous cross-section of the Nepalese population. Demographic data, including age and gender, as well as health data, such as diabetic subclass (i.e., Type 1 or Type 2) and interval from diagnosis to presentation at TIO, were collected. DR was determined to be present through the presence of any retinal vascular abnormalities consistent with this entity – “dot-blot” hemorrhages, microaneurysms, cotton-wool spots, intraretinal microvascular abnormalities, and/or venous beading. In addition, data regarding its staging and severity, the presence or absence of neovascularization, and initial treatment modality (if any required) were noted. To eliminate the extensive variability in attempting to retrospectively substage PDR and NPDR (e.g., mild, moderate, severe), patients were grouped as either “no DR,” “NPDR” (retinal manifestations without neovascularization), and “PDR” (any neovascularization). In addition, the presence or absence of diabetic macular edema (DME) was noted. DR severity for an individual patient was determined according to the staging of the eye with the most severe disease manifestations.

All patient data were appropriately deidentified. This study was approved by the Institutional Review Committee at TIO and adhered to the tenets of the Declaration of Helsinki.

Inclusion/exclusion criteria

Patient records were included in the review if they (a) presented to TIO during the study period from 2012 to 2014, (b) carried a diagnosis of either Type 1 or Type 2 DM at the time of initial presentation, (c) were adult patients >18 years of age at the time of initial presentation, and (d) did not meet any of the exclusion criteria. Patients were excluded if a fundus examination had not been performed at the initial visit (often precluded due to coexisting ocular comorbidities, such as mature cataract), if there was a history of potentially confounding medical conditions (e.g., known hypertensive retinopathy, infection with human immunodeficiency virus, history of ocular radiation, hemoglobinopathy), or if the DM was not classified as Type 1 or Type 2, such as gestational diabetes or steroid-induced diabetes.

Data analysis

For categorical variables, a Chi-square test was used; for continuous variables, Student's t-test or ANOVA test was used for mean difference, where applicable. Statistical analysis was performed using IBM SPSS Statistics (version 20, IBM, Armonk, NY, USA). Statistical significance was set at P < 0.05.


   Results Top


Altogether, 8855 patients were identified who presented with DM during the study period [Table 2]. Of these 8855 cases, 2578 presented in 2012, 2853 in 2013, and the final 3424 in 2014. The overall gender ratio of the patients was 1.2:1 (M:F), with a similar gender distribution in all years studied. Male gender was significantly associated with the presence of DR at initial presentation (P < 0.001, Chi-square test). The mean patient age at time of presentation was 56.9 years (standard deviation ± 11.9 years), and this varied little for each individual year of the study period. The study population was skewed almost entirely toward patients with type 2 DM (8586 patients, 97%), with only 3% (269 patients) reporting a diagnosis of type 1 DM. This was similar across all years of the study period.
Table 2: Demographics, diabetic retinopathy, and severity of participants at the time of presentation (n=8855)

Click here to view


The overall prevalence of DR (any stage) among all patients with DM at the time of initial presentation was 19.4% (95% confidence interval [CI] 17.5–21.2). This prevalence was fairly consistent across the 3-year study period, with the prevalence rates of 19.5% (95% CI 16.0–22.9) in 2012, 21.7% (95% CI 18.5–25.0) in 2013, and 17.3% (95% CI 14.2–20.3) in 2014.

Of all cases presenting with DR, over half presented with NPDR (1305 patients, 76.1%), for an overall prevalence of 14.7% among all patients with DM. Of patients with NPDR, 416 (24.3% of patients with DR) were noted to have concomitant DME. The remaining 409 patients (23.9% of all cases with DR) presented with PDR, for an overall prevalence of 4.6% among patients presenting with DM, with 201 of these patients (11.7% of patients with DR) having concomitant DME. Across all years of the study, 915 patients (53.4% of patients with DR) were referred for treatment (laser, intravitreal pharmacologics, and/or surgery) at the time of initial presentation.

Forty-eight percent of the overall cohort had an additional systemic comorbidity, and hypertension was the primary comorbidity in 99.5% of all cases with DM [Table 3]. The remaining 0.5% demonstrated a diverse array of comorbidities, including asthma, chronic obstructive pulmonary disease, heart disease, tuberculosis infection, and thyroid dysfunction. Not surprisingly, hypertension was significantly associated with the presence of DR at the initial presentation (P < 0.001, Chi-square test).
Table 3: Factors associated with diabetes mellitus and concurrent diabetic retinopathy

Click here to view


The mean duration from initial DM diagnosis to initial eye consultation was also significantly associated with the presence of DR (P < 0.05, one-way ANOVA), with a mean duration of 7.4 years (range: <1 month–48 years) reported across the study period. Less than half the diabetic cohort, 43.2%, presented for an ophthalmic examination within 5 years of their initial diagnosis. An additional 24.3% of patients only sought consultation within the first decade after their diagnosis. No clear trend toward earlier presentation across the study window was noted, with similar patterns of presentation across all 3 years.


   Discussion Top


DM and its ophthalmic complications represent a massive, and growing, public health concern, and one that is especially concerning in low-to-middle-income countries where resources are limited and access to care is difficult.[18] Nepal, like other countries in South Asia, appears to have a nascent epidemic of DM and DR, but published data have been widely varied.[5],[6],[8],[9],[10],[11],[12],[13],[14],[15] Previous studies were based on relatively small sample sizes [Table 1], so we first sought to examine a larger cross-section of diabetic patients. With a primary cohort of 8855 patients, this stands as the largest review in Nepal to date, and as such, it likely serves as the most reliable source of the in-country DR prevalence for all DM patients presenting for care thus far. A few conclusions may be cautiously drawn from these data then, in spite of the retrospective nature of this study:{Table 1}

First, the DR incidence among patients with DM in Nepal likely accords with the lower end of previously published estimates. The overall prevalence of DR across all years for DM patients presenting to TIO was 19.4%, and this correlates most closely to the two prior studies from the Nepali literature by Shrestha and Shrestha etal.[5],[7] Acknowledging certain limitations within the study design, as well as the selection bias introduced by examining only the population presenting for ophthalmic examination, this is likely the most accurate estimate, to date, for DR prevalence in Nepal's diabetic population. In addition, its near-exact correlation with the community-based study performed by Paudyal et al. lends further credence to this determination.[12]

Second, although likely confirming lower estimates of DR prevalence, the public health concern herein is in no way diminished, as over half of the patients found to have DR upon initial evaluation presented with a vision-threatening complication warranting some measure of initial treatment (i.e., DME and/or PDR). This correlates with the choice for initial therapy among patients found to have DR, with 53.4% being referred immediately for some mode of intervention (laser, intravitreal pharmacologics, and/or surgery), with the vast majority of these cases receiving multimodal therapy.

Third, no dramatic shifts in DR prevalence, severity, or risk factors were noted, over the 3 years of the study period, referral characteristics, demographic data, and DR severity remained relatively stable. This lends credence to our estimates of DR prevalence but does not reveal any changes in public health awareness as, perhaps, a broader population-based study or longer study period might. Future studies may seek to examine these possibilities in greater detail and over longer periods of time. The only exception to this stability was a slight uptick in the number of patient presentations during each year of the study period [Table 2], which may reflect the influence of a number of factors: steadily increasing patient volume at TIO, increasing community awareness of diabetic care, or improving networks of patient referrals, for instance.{Table 2}

Correlating patient and provider awareness of the risks of DR may be an additional area for future study. In previous studies from Nepal, awareness of the deleterious effects of DR and the need among diabetic patients for screening has been low.[6],[12] Various studies cite the need for improved patient education and coordination with primary care providers[6],[7],[8],[12] and increased awareness of DR has been correlated with improved uptake of health services.[19] More accurate data reflecting the prevalence and severity of DR in the Nepali population can assist in these efforts, and our study represents a significant step in that direction.

Certain study limitations do add a measure of caution to our conclusions. As a retrospective study, our study sample is inevitably subject to bias, as it was based in a tertiary care eye center, our cohort may be skewed toward more severe disease, artificially increasing the prevalence of more severe cases of vision-altering DR. Next, our sample was drawn largely from the Kathmandu Valley (with the majority from the urban environs of Kathmandu) and may not reflect the prevalence of DR in the more rural communities of this country. Increased male incidence among patients with DR upon presentation may reflect a true risk factor, or it may reveal gender inequities in access to care, as has been noted previously in some Nepali populations.[20] However, the consistency of DR prevalence and severity across all 3 years of the study period (in spite of variable patient numbers), as well as their approximation of the one prior community-based cross-sectional study,[12] help affirm the observations of this study.

Finally, as the study examined a population of patients being referred to a tertiary eye care center, the results may have been affected by some selection bias in favor of increased disease prevalence (as compared to the actual population prevalence) and increased disease severity (as compared to the actual diabetic population). A 2016 review of approximately 650 patients with DR, selected from the general population using cluster sampling methods, found a much higher proportion of NPDR and lower prevalence of more advanced complications such as DME and PDR (of note, this study also found a DR prevalence of 12% among patients with DM, which approximates the prevalence reported herein).[13] In contrast, a 2017 review of 50 DR patients from an alternate location in the Kathmandu valley demonstrated a PDR prevalence of over 30% among patients with DR, over twice what was detected in our study, and almost five times that found in the 2016 review.[21]

This review detected a more average prevalence between these two extremes, and two details (beyond the number of patients assessed) seem to strengthen the claims of our data in reflecting a more general population: first, although providing tertiary-level ophthalmic care, the TIO receives patients through multiple referral channels, including self-referral and primary care, and therefore, examines a more cross-sectional population than the standard tertiary care center. Second, the correlation of our data with the lower prevalence estimates provided by both published community-based studies (rather than an inflated, higher estimate) supports the concordance of this large study with prior, smaller community surveys.


   Conclusions Top


In summary, we present here the largest cross-sectional survey of the prevalence and severity of DR from a diabetic population in Nepal. We observed a prevalence of DR in this population that was lower than previous estimates, but consistent with a prior community-based survey from Nepal; however, among patients with DR, nearly half presented with a vision-threatening complication requiring initial treatment. These data affirm the growing public health threat of diabetes and its complications and the need for ongoing education and equipping of the ophthalmic community.

Financial support and sponsorship

This study was sponsored through the research department at the Tilganga Institute of Ophthalmology.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9.  Back to cited text no. 1
    
2.
Vision Problems in the United States. Data Analysis: Definitions, Data Sources, Detailed Data Tables, Analysis, Interpretation. New York: National Society to Prevent Blindness; 1989. p. 1-46.  Back to cited text no. 2
    
3.
Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.  Back to cited text no. 3
    
4.
Thapa SS, Thapa R, Paudyal I, Khanal S, Aujla J, Paudyal G, et al. Prevalence and pattern of vitreo-retinal diseases in Nepal: The Bhaktapur glaucoma study. BMC Ophthalmol 2013;13:9.  Back to cited text no. 4
    
5.
Shrestha RK. Ocular manifestations in diabetes, a hospital based prospective study. Nepal Med Coll J 2011;13:254-6.  Back to cited text no. 5
    
6.
Thapa R, Poudyal G, Maharjan N, Bernstein PS. Demographics and awareness of diabetic retinopathy among diabetic patients attending the vitreo-retinal service at a tertiary eye care center in Nepal. Nepal J Ophthalmol 2012;4:10-6.  Back to cited text no. 6
    
7.
Shrestha S, Malla OK, Karki DB, Byanju RN. Retinopathy in a diabetic population. Kathmandu Univ Med J 2007;5:204-9.  Back to cited text no. 7
    
8.
Shrestha MK, Paudyal G, Wagle RR, Gurung R, Ruit S, Onta SR, et al. Prevalence of and factors associated with diabetic retinopathy among diabetics in Nepal: A hospital based study. Nepal Med Coll J 2007;9:225-9.  Back to cited text no. 8
    
9.
Rizyal A. Ocular manifestations in diabetes mellitus: An experience at Nepal medical college teaching hospital. Nepal Med Coll J 2004;6:136-8.  Back to cited text no. 9
    
10.
Ramavat PR, Ramavat MR, Ghugare BW, Vaishnav RG, Joshi MU. Prevalence of diabetic retinopathy in Western Indian type 2 diabetic population: A hospital – Based cross – Sectional study. J Clin Diagn Res 2013;7:1387-90.  Back to cited text no. 10
    
11.
Wahab S, Mahmood N, Shaikh Z, Kazmi WH. Frequency of retinopathy in newly diagnosed type 2 diabetes patients. J Pak Med Assoc 2008;58:557-61.  Back to cited text no. 11
    
12.
Paudyal G, Shrestha MK, Meyer JJ, Thapa R, Gurung R, Ruit S, et al. Prevalence of diabetic retinopathy following a community screening for diabetes. Nepal Med Coll J 2008;10:160-3.  Back to cited text no. 12
    
13.
Mishra SK, Pant BP, Subedi P. The prevalence of diabetic retinopathy among known diabetic population in Nepal. Kathmandu Univ Med J (KUMJ) 2016;14:134-9.  Back to cited text no. 13
    
14.
Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V, et al. Prevalence of diabetic retinopathy in urban India: The Chennai urban rural epidemiology study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005;46:2328-33.  Back to cited text no. 14
    
15.
Ahmed KR, Karim MN, Bhowmik B, Habib SH, Bukht MS, Ali L, et al. Incidence of diabetic retinopathy in Bangladesh: A 15-year follow-up study. J Diabetes 2012;4:386-91.  Back to cited text no. 15
    
16.
Huang OS, Tay WT, Tai ES, Wang JJ, Saw SM, Jeganathan VS, et al. Lack of awareness amongst community patients with diabetes and diabetic retinopathy: The Singapore Malay eye study. Ann Acad Med Singapore 2009;38:1048-55.  Back to cited text no. 16
    
17.
Brian G, Fischer-Harder K, Sikivou B, Qoqonokana MQ, Szetu J, Ramke J, et al. Diabetic eye disease among adults in Fiji with self-reported diabetes. Clin Exp Ophthalmol 2010;38:867-74.  Back to cited text no. 17
    
18.
Jha P, Mills A, Hanson K, Kumaranayake L, Conteh L, Kurowski C, et al. Improving the health of the global poor. Science 2002;295:2036-9.  Back to cited text no. 18
    
19.
Wang D, Ding X, He M, Yan L, Kuang J, Geng Q, et al. Use of eye care services among diabetic patients in urban and rural China. Ophthalmology 2010;117:1755-62.  Back to cited text no. 19
    
20.
Wilson ME, Hennig A, Trivedi RH, Thomas BJ, Singh SK. Clinical characteristics and early postoperative outcomes of pediatric cataract surgery with IOL implantation from Lahan, Nepal. J Pediatr Ophthalmol Strabismus 2011;48:286-91.  Back to cited text no. 20
    
21.
Pandey A, Lamichhane G, Khanal R, Rai SK, Bhari AM, Borroni D, et al. Assessment of visual morbidity amongst diabetic retinopathy at tertiary eye care center, Nepal: A cross-sectional descriptive study. BMC Ophthalmol 2017;17:263.  Back to cited text no. 21
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3]



 

Top
  
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
    Materials and Me...
   Results
   Discussion
   Conclusions
    References
    Article Tables

 Article Access Statistics
    Viewed253    
    Printed0    
    Emailed0    
    PDF Downloaded12    
    Comments [Add]    

Recommend this journal